Nuwellis (NUWE) Capital Expenditures Growth (1y) (2012 - 2026)
Nuwellis (NUWE) Capital Expenditures Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -6.52% |
| 10 | Nuwellis | 212,054.30 | -3.71 Mn | 1.50 Mn | 272.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 272.64% |
| Dec 31, 2025 | -152.17% |
| Sep 30, 2025 | 712.50% |
| Jun 30, 2025 | -83.33% |
| Dec 31, 2024 | 163.89% |
| Sep 30, 2024 | -113.22% |
| Jun 30, 2024 | -52.94% |
| Mar 31, 2024 | 123.08% |
| Dec 31, 2023 | -289.47% |
| Sep 30, 2023 | 450.00% |
| Jun 30, 2023 | 363.64% |
| Mar 31, 2023 | -81.43% |
| Dec 31, 2022 | -32.14% |
| Sep 30, 2022 | -59.26% |
| Jun 30, 2022 | -86.42% |
| Mar 31, 2022 | 25.00% |
| Dec 31, 2021 | -69.23% |
| Sep 30, 2021 | -60.87% |
| Jun 30, 2021 | 55.77% |
| Mar 31, 2021 | 229.41% |